Understanding the effects of RAF inhibitors on RAF signaling in B-RAF V600E mutant versus wild type tumors

被引：0
|
作者：
Yen, Ivana
Song, Kyung
Stokoe, David
Brandhuber, Barbara
Gloor, Susan
Aliagas, Ignacio
Anderson, Daniel
Morales, Tony
Vigers, Guy
Ludlam, Mary
Alvarado, Ryan
Liu, Bonnie
Sideris, Steve
Ramaswamy, Sreema
Heise, Christopher
Belvin, Marcia
Friedman, Lou
Hatzivassiliou, Georgia
Malek, Shiva
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-B90
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B90
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
    Li, Yisu
    Guo, Binbin
    Xu, Zhijian
    Li, Bo
    Cai, Tingting
    Zhang, Xinben
    Yu, Yuqi
    Wang, Heyao
    Shi, Jiye
    Zhu, Weiliang
    SCIENTIFIC REPORTS, 2016, 6
  • [32] Circumventing Paradoxical Drug-induced Activation of the MAPK Pathway with Next Generation B-RAF V600E Inhibitors
    Vernier, J. M.
    Matthews, D.
    Pearson, P.
    Hershenson, S.
    Freddo, J.
    Giaccia, A. J.
    Tabibiazar, R.
    O'Connor, P. M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 125 - 125
  • [33] Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
    Yisu Li
    Binbin Guo
    Zhijian Xu
    Bo Li
    Tingting Cai
    Xinben Zhang
    Yuqi Yu
    Heyao Wang
    Jiye Shi
    Weiliang Zhu
    Scientific Reports, 6
  • [34] Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling
    Liu, Longbin
    Lee, Matthew R.
    Kim, Joseph L.
    Whittington, Douglas A.
    Bregman, Howard
    Hua, Zihao
    Lewis, Richard T.
    Martin, Matthew W.
    Nishimura, Nobuko
    Potashman, Michele
    Yang, Kevin
    Yi, Shuyan
    Vaida, Karina R.
    Epstein, Linda F.
    Babij, Carol
    Fernando, Manory
    Carnahan, Josette
    Norman, Mark H.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (10) : 2215 - 2234
  • [35] Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation
    Zaharie, Florin
    Petric, Roxana Cojocneanu
    Muresan, Mihai
    Frinc, Ioana
    Dima, Delia
    Petrushev, Bobe
    Tanase, Alina
    Berce, Cristian
    Chitic, Mariana
    Berindan-Neagoe, Ioana
    Pileczki, Valentina
    Irimie, Alexandru
    Tomuleasa, Ciprian
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10
  • [36] Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway
    Gaggioli, Cedric
    Robert, Guillaume
    Bertolotto, Corine
    Bailet, Olivier
    Abbe, Patricia
    Spadafora, Anne
    Bahadoran, Philippe
    Ortonne, Jean-Paul
    Baron, Veronique
    Ballotti, Robert
    Tartare-Deckert, Sophie
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (02) : 400 - 410
  • [37] Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction Breakdown
    Zhang, Pu
    Feng, Shan
    Liu, Gentao
    Wang, Heyong
    Zhu, Huifeng
    Ren, Qiao
    Bai, Huiyuan
    Fu, Changliang
    Dong, Cheng
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (05) : 2087 - 2106
  • [38] A B-Raf V600E gene signature for melanoma predicts prognosis and reveals sensitivity to targeted therapies
    Yao, Kevin
    Zhou, Emily
    Cheng, Chao
    CANCER MEDICINE, 2022, 11 (04): : 1232 - 1243
  • [39] B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules
    Bentz, Brandon G.
    Miller, Brian T.
    Holden, Joseph A.
    Rowe, Leslie R.
    Bentz, Joel S.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2009, 140 (05) : 709 - 714
  • [40] Absence of V600E B-RAF Mutation in MLH1-Negative Endometrial Carcinoma.
    Musulen, E.
    Munoz-Marmol, A. M.
    Sanz, C.
    Carrato, C.
    Mate, J. L.
    Ariza, A.
    LABORATORY INVESTIGATION, 2011, 91 : 261A - 261A
12345